Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 0 Study Evaluating the Systemic Bioavailability and Pharmacodynamic Effects of Avmacol® in the Oral Mucosa of Patients Following Curative Treatment for Tobacco-related Head and Neck Cancer

NCT03268993 is registered in ClinicalTrials.gov with University of Pittsburgh as lead sponsor.

NCT NCT03268993
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03268993 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 0 Study Evaluating the Systemic Bioavailability and Pharmacodynamic Effects of Avmacol® in the Oral Mucosa of Patients Following Curative Treatment for Tobacco-related Head and Neck Cancer
Lead sponsor
University of Pittsburgh
Phase
Not applicable
Overall status
Completed
Start date
July 27, 2018
Completion date
July 22, 2019
Enrollment
6 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma in situ, dysplasia, head and neck, head and neck cancer, head and neck carcinoma, head and neck squamous cell carcinoma (hnscc), hyperplasia, premalignant lesion, tobacco-related carcinoma